Financials

News Discussions Technicals Forecast Seasonals Options

SGMT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Sagimet Biosciences Inc. - Series A

Total assets of SGMT for Q4 24 is 160.26 M USD, 8.31% less than the previous Q3 24. And total liabilities increased by 8.85% in Q4 24 to 4.45 M USD.

Q1 '20

Q1 '21

Q1 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '20

Q1 '21

Q1 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—